Induction of lymphokine-activated killer cells with low-dose interleukin 2 and interferon-? in oral cancer patients

1992 ◽  
Vol 12 (4) ◽  
pp. 289-299 ◽  
Author(s):  
Kazunori Yoneda ◽  
Tetsuya Yamamoto ◽  
Eisaku Ueta ◽  
Tokio Osaki
Keyword(s):  
Oral Cancer ◽  
Cancer Patients ◽  
Low Dose ◽  
Interleukin 2 ◽  
Lymphokine Activated Killer Cells ◽  
Killer Cells ◽  
Oral Cancer Patients

Quality of Life of Oral Cancer Patients After Low-Dose-Rate Interstitial Brachytherapy

2009 ◽  
Vol 73 (3) ◽  
pp. 772-778 ◽  
Author(s):  
Ryo-ichi Yoshimura ◽  
Hitoshi Shibuya ◽  
Masahiko Miura ◽  
Hiroshi Watanabe ◽  
Fumio Ayukawa ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Oral Cancer ◽  
Dose Rate ◽  
Cancer Patients ◽  
Low Dose ◽  
Interstitial Brachytherapy ◽  
Low Dose Rate ◽  
Oral Cancer Patients

scholarly journals Disease control using low-dose-rate brachytherapy is unaffected by comorbid severity in oral cancer patients

2011 ◽  
Vol 84 (1006) ◽  
pp. 930-938 ◽  
Author(s):  
R Yoshimura ◽  
H Shibuya ◽  
K Hayashi ◽  
K Toda ◽  
H Watanabe ◽  
...  
Keyword(s):  
Oral Cancer ◽  
Disease Control ◽  
Dose Rate ◽  
Cancer Patients ◽  
Low Dose ◽  
Low Dose Rate ◽  
Oral Cancer Patients ◽  
Low Dose Rate Brachytherapy

In vivo administration of low-dose human interleukin-2 induces lymphokine-activated killer cells for enhanced cytolysis in vitro

1991 ◽  
Vol 132 (2) ◽  
pp. 277-284 ◽  
Author(s):  
Gerald E. Hancock ◽  
Anthony Molloy ◽  
A.B. Birhane Kale ◽  
Rolf Kiessling ◽  
Marijke Becx-Bleumink ◽  
...  
Keyword(s):  
Low Dose ◽  
Interleukin 2 ◽  
Lymphokine Activated Killer Cells ◽  
Killer Cells ◽  
In Vivo Administration

An Outbreak of Hepatitis A among Cancer Patients Treated with Interleukin-2 and Lymphokine-Activated Killer Cells

1990 ◽  
Vol 161 (4) ◽  
pp. 647-652 ◽  
Author(s):  
I. B. Weisfuse ◽  
D. J. Graham ◽  
M. Will ◽  
D. Parkinson ◽  
D. R. Snydman ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Hepatitis A ◽  
Interleukin 2 ◽  
Lymphokine Activated Killer Cells ◽  
Killer Cells

Immunomodulatory effects of systemic low-dose recombinant interleukin-2 and lymphokine-activated killer cells in humans

1989 ◽  
Vol 30 (3) ◽  
pp. 145-150 ◽  
Author(s):  
Timothy J. Eberlein ◽  
Mary L. Rodrick ◽  
Anthony F. Massaro ◽  
Sung-Eun Jung ◽  
John A. Mannick ◽  
...  
Keyword(s):  
Low Dose ◽  
Interleukin 2 ◽  
Immunomodulatory Effects ◽  
Lymphokine Activated Killer Cells ◽  
Killer Cells ◽  
Recombinant Interleukin 2
Sign in / Sign up

Export Citation Format

Share Document